Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (BEIGF) Net Income - Minority (2017 - 2020)

BeOne Medicines (BEIGF) has disclosed Net Income - Minority for 4 consecutive years, with -$9.1 million as the latest value for Q3 2020.

  • Quarterly Net Income - Minority rose 42.15% to -$9.1 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$9.1 million through Sep 2020, up 42.15% year-over-year, with the annual reading at -$16.2 million for FY2019, 11.8% down from the prior year.
  • Net Income - Minority for Q3 2020 was -$9.1 million at BeOne Medicines, up from -$10.2 million in the prior quarter.
  • The five-year high for Net Income - Minority was -$9.1 million in Q3 2020, with the low at -$17.4 million in Q2 2019.
  • Average Net Income - Minority over 4 years is -$13.9 million, with a median of -$14.4 million recorded in 2017.
  • The sharpest move saw Net Income - Minority dropped 21.36% in 2019, then skyrocketed 42.15% in 2020.
  • Over 4 years, Net Income - Minority stood at -$14.4 million in 2017, then dropped by 0.16% to -$14.4 million in 2018, then fell by 11.8% to -$16.2 million in 2019, then surged by 43.55% to -$9.1 million in 2020.
  • According to Business Quant data, Net Income - Minority over the past three periods came in at -$9.1 million, -$10.2 million, and -$14.8 million for Q3 2020, Q2 2020, and Q1 2020 respectively.